摘要
目的:探讨交叉反应组(CREGs)配型在肾移植中的应用价值。方法:对173例肾移植患者分别采用CREGs配型原则和HLA配型原则的配型情况并对其术后急性排斥反应情况进行相关分析。结果:HLA配型A、B、DR位点0(抗原错配)MM的比率分别为7.51%、4.04%、3.46%,2MM的比率分别为39.88%、65.31%、58.38%;而应用CREGs配型A、B、DR位点0MM的比率分别为49.71%、30.63%、24.27%,2MM的比率分别为5.20%、12.14%、8.67%。HLA配型A、B、DR位点0MM急性排斥反应发生率分别为21.96%、21.38%、7.51%,2MM分别为22.54%、20.23%、66.67%;CREGs配型A、B、DR位点0MM急性排斥反应发生率分别为21.83%、20.21%、6.14%,2MM分别为22.22%、20.00%、69.82%。结论:CREGs配型原则能够有效提高供肾利用率,是一种新的选择肾移植供-受者的配型的方法。
Objective:To study the applied value of CREG Zygosity Principles in kidney transplantation.Methods:Relationship between HLA CREG zygosity and acute rejection incidence was analyzed in 173 kidney transplantation and the concerned principles were discussed.Results:HLA-A,B,DR antigens of 0 mismatch (MM) were 7.51%,4.04%,3.46%;and those of 2 MM were 39.88%,65.31%,58.38% respectively.Compared in CREGs,A,B,and DR,the 0 MMs were 49.71%,30.63% and 24.27%;whereas 2MMs were only 5.20%,12.14% and 8.67%.In HLA-A,B and DR antigens 0 MM,the incidence of acute rejection was 21.96%,21.38% and 7.51% respectively;and in 2MMs,those were 22.54%,20.23%,and 66.67% respectively.Compared by CREGs A,B and DR 0 MM,acute rejection reached 21.83%,20.21% and 6.14%;and in 2MMs the incidence of acute rejection were 22.22%,20.00% and 69.82%.Conclusion:CREGs model is a novel method of choosing kidney transplantation donor-recipients’s matching.
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
2008年第10期899-901,共3页
Chinese Journal of Immunology
基金
吉林省科技厅科技发展计划项目(200505154)
关键词
肾移植
配型
排斥反应
Kidney transplantation
Zygosity
Rejection